J Moreno Izarra, A Brunst, J A Carmona Álvarez, F Aranda, J M Mártir Alario
{"title":"[确定oritavancin的新治疗方案:免疫功能严重受损的肿瘤患者的严重细菌性金黄色葡萄球菌皮肤和软组织感染]。","authors":"J Moreno Izarra, A Brunst, J A Carmona Álvarez, F Aranda, J M Mártir Alario","doi":"10.37201/req/055.2023","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"645-647"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10710684/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient].\",\"authors\":\"J Moreno Izarra, A Brunst, J A Carmona Álvarez, F Aranda, J M Mártir Alario\",\"doi\":\"10.37201/req/055.2023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94198,\"journal\":{\"name\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"volume\":\" \",\"pages\":\"645-647\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10710684/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37201/req/055.2023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37201/req/055.2023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/11 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
[Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient].